Fig. 2From: Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapyRatio proteasome subunit protein expression in patients who achieved complete remission versus patients who did not, dissected by leukaemia subtype. Ratios of immunoproteasome/constitutive proteasome protein expression in a AML patients, b pre-B ALL patients and c T-ALL patients that achieved CR versus patients who did not achieve CR, determined by Western blot analysis after bortezomib-containing re-induction therapy. The line denotes the meanBack to article page